These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9756852)

  • 1. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta.
    Pal S; Claffey KP; Cohen HT; Mukhopadhyay D
    J Biol Chem; 1998 Oct; 273(41):26277-80. PubMed ID: 9756852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.
    Pal S; Claffey KP; Dvorak HF; Mukhopadhyay D
    J Biol Chem; 1997 Oct; 272(44):27509-12. PubMed ID: 9346879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
    Mukhopadhyay D; Knebelmann B; Cohen HT; Ananth S; Sukhatme VP
    Mol Cell Biol; 1997 Sep; 17(9):5629-39. PubMed ID: 9271438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression.
    Pal S; Datta K; Khosravi-Far R; Mukhopadhyay D
    J Biol Chem; 2001 Jan; 276(4):2395-403. PubMed ID: 11060301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association.
    Cohen HT; Zhou M; Welsh AM; Zarghamee S; Scholz H; Mukhopadhyay D; Kishida T; Zbar B; Knebelmann B; Sukhatme VP
    Biochem Biophys Res Commun; 1999 Dec; 266(1):43-50. PubMed ID: 10581162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
    Reisinger K; Kaufmann R; Gille J
    J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
    Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
    Gille J; Swerlick RA; Caughman SW
    EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S; Datta K; Mukhopadhyay D
    Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.
    Neid M; Datta K; Stephan S; Khanna I; Pal S; Shaw L; White M; Mukhopadhyay D
    J Biol Chem; 2004 Feb; 279(6):3941-8. PubMed ID: 14604996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways.
    Suzuma I; Suzuma K; Ueki K; Hata Y; Feener EP; King GL; Aiello LP
    J Biol Chem; 2002 Jan; 277(2):1047-57. PubMed ID: 11694503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
    Iliopoulos O; Levy AP; Jiang C; Kaelin WG; Goldberg MA
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10595-9. PubMed ID: 8855223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1.
    Tan NY; Midgley VC; Kavurma MM; Santiago FS; Luo X; Peden R; Fahmy RG; Berndt MC; Molloy MP; Khachigian LM
    Circ Res; 2008 Feb; 102(4):e38-51. PubMed ID: 18258854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes.
    Tanaka T; Kanai H; Sekiguchi K; Aihara Y; Yokoyama T; Arai M; Kanda T; Nagai R; Kurabayashi M
    J Mol Cell Cardiol; 2000 Nov; 32(11):1955-67. PubMed ID: 11040101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts.
    Milanini J; Viñals F; Pouysségur J; Pagès G
    J Biol Chem; 1998 Jul; 273(29):18165-72. PubMed ID: 9660776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.